+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Epilepsy Drug"

From
Dravet Syndrome Market - Global Strategic Business Report - Product Thumbnail Image

Dravet Syndrome Market - Global Strategic Business Report

  • Report
  • December 2025
  • 485 Pages
  • Global
From
Barbiturate Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Barbiturate Drugs Market - Global Strategic Business Report

  • Report
  • December 2025
  • 386 Pages
  • Global
From
Phenobarbital Market - Global Strategic Business Report - Product Thumbnail Image

Phenobarbital Market - Global Strategic Business Report

  • Report
  • December 2025
  • 362 Pages
  • Global
From
Pediatric Epilepsy Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pediatric Epilepsy Therapeutics - Global Strategic Business Report

  • Report
  • December 2025
  • 184 Pages
  • Global
From
From
Cannabidiol - Global Strategic Business Report - Product Thumbnail Image

Cannabidiol - Global Strategic Business Report

  • Report
  • December 2025
  • 377 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • December 2025
  • 506 Pages
  • Global
From
From
From
From
From
West Syndrome Market Report and Forecast 2025-2034 - Product Thumbnail Image

West Syndrome Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Dravet Syndrome (DS) Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Dravet Syndrome (DS) Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Seizures Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Seizures Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Brain Hemorrhage Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Brain Hemorrhage Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Tuberous Sclerosis Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Tuberous Sclerosis Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Epilepsy - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Epilepsy - Global Clinical Trials Review, 2025

  • Clinical Trials
  • September 2025
  • 2081 Pages
  • Global
From
From
From
Loading Indicator

The Epilepsy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Epilepsy drugs are used to treat seizures, which are caused by abnormal electrical activity in the brain. These drugs work by either suppressing the abnormal electrical activity or increasing the amount of neurotransmitters in the brain. Commonly used epilepsy drugs include anticonvulsants, benzodiazepines, and barbiturates. Epilepsy drugs are used to treat a wide range of seizure types, including tonic-clonic seizures, absence seizures, and myoclonic seizures. They are also used to treat other neurological disorders, such as bipolar disorder and anxiety. The market for epilepsy drugs is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more